Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-04-17 pm EDT 5-day change 1st Jan Change
239.4 USD -0.40% Intraday chart for Danaher Corporation -2.64% +3.48%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AdaptHealth Names Suzanne Foster as CEO MT
AdaptHealth Names Suzanne Foster CEO DJ
The market is pinning its hopes on earnings reports Our Logo
HSBC Upgrades Danaher to Buy From Hold, Adjusts Price Target to $280 From $250 MT
ANALYST RECOMMENDATIONS : Las Vegas Sands, Regeneron, Kinder Morgan, Rivian, Royal Caribbean... Our Logo
Leerink Partners Adjusts Danaher's Price Target to $265 From $255 MT
As You Sow Files an Exempt Solicitation Statement with Securities and Exchange Commission CI
RBC Lifts Price Target on Danaher to $284 From $282, Keeps Outperform Rating MT
Danaher Files Mixed Shelf MT
Danaher Corporation Receives Shareholder Proposal from Eliana Fishman CI
Danaher Corporation Receives Shareholder Proposal from John Chevedden CI
Transcript : Danaher Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 11:10 AM
Agilent reports better-than-expected first quarter results, shares rise RE
Danaher Insider Sold Shares Worth $5,986,764, According to a Recent SEC Filing MT
Danaher Raises Quarterly Dividend to $0.27 Per Share From $0.24, Payable April 26 to Shareholders of Record March 28 MT
Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 26, 2024 CI
Danaher Insider Sold Shares Worth $826,032, According to a Recent SEC Filing MT
The latest transactions by star fund managers Our Logo
Danaher Insider Sold Shares Worth $636,290, According to a Recent SEC Filing MT
Danaher Corporation Announces Retirement of Walter G. Lohr, Jr. from the Board CI
Danaher Insider Sold Shares Worth $816,724, According to a Recent SEC Filing MT
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development CI
KeyBanc Raises Price Target on Danaher to $290 From $260, Maintains Overweight Rating MT
UBS Raises Danaher Price Target to $283 From $270, Maintains Buy Rating MT
Deutsche Bank Adjusts Danaher Price Target to $270 From $250, Maintains Buy Rating MT
Chart Danaher Corporation
More charts
Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
239.4 USD
Average target price
264.9 USD
Spread / Average Target
+10.65%
Consensus